Go Pro

CapsoVision (CV) 10K Form and Latest SEC Filings 2026

CapsoVision logo
$6.39 +0.06 (+0.95%)
Closing price 04:00 PM Eastern
Extended Trading
$6.39 0.00 (0.00%)
As of 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest CapsoVision SEC Filings & Recent Activity

CapsoVision (NASDAQ:CV) has submitted 83+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 4 submitted on July 10, 2026.

Form 4
CapsoVision, Inc Reports Ownership Change on Jul. 10, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
CapsoVision Files Current Report on Jun. 12, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
CapsoVision Files Quarterly Report on May. 14, 2026

The 10-Q contains CapsoVision's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

CapsoVision SEC Filing History

Browse CapsoVision's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
07/10/2026 7:17 PM
CapsoVision (1378325) Issuer
HARARI ELIYAHOU ET AL (1009165) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2026 9:03 PM
CapsoVision (1378325) Issuer
HARARI ELIYAHOU ET AL (1009165) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 8:21 PM
CapsoVision (1378325) Issuer
Imperial Joanne Carol (2075511) Reporting
Form 4/A
07/01/2026 8:22 PM
CapsoVision (1378325) Issuer
Imperial Joanne Carol (2075511) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 7:17 PM
CapsoVision (1378325) Issuer
GOUW JULIA S (1235498) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 7:18 PM
CapsoVision (1378325) Issuer
Harari Michele (2074161) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 7:18 PM
CapsoVision (1378325) Issuer
King Wen-Herng Henry (2074258) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 7:18 PM
CapsoVision (1378325) Issuer
Kuo Hui Ying (2074262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 7:19 PM
CapsoVision (1378325) Issuer
Tsai Chen Lung (1307275) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2026 1:14 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2026 1:14 PM
Atkinson Douglas Patrick (2074105) Reporting
CapsoVision (1378325) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 1:15 PM
CapsoVision (1378325) Issuer
Garcia David Michael (2093112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 1:16 PM
CapsoVision (1378325) Issuer
Wang Kang-Huai (2075513) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2026 3:35 PM
CapsoVision (1378325) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 6:00 PM
CapsoVision (1378325) Subject
HARARI ELIYAHOU ET AL (1009165) Filed by
Form SCHEDULE 13G/A
05/06/2026 11:50 AM
Atkinson Douglas Patrick (2074105) Reporting
CapsoVision (1378325) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2026 11:39 AM
CapsoVision (1378325) Filer
Form DEF 14A
04/22/2026 11:15 PM
CapsoVision (1378325) Filer
Form EFFECT
04/17/2026 3:34 PM
CapsoVision (1378325) Filer
Form S-1
Registration statement under Securities Act of 1933  
04/15/2026 9:23 AM
CapsoVision (1378325) Subject
Shen Ching Hang (2102304) Filed by
Form SCHEDULE 13G/A
04/07/2026 3:58 PM
CapsoVision (1378325) Subject
CID Greater China Venture Capital Fund III, L.P. (2092240) Filed by
Form SCHEDULE 13G/A
03/30/2026 2:52 PM
CapsoVision (1378325) Issuer
Shen Ching Hang (2102304) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/26/2026 8:46 PM
CapsoVision (1378325) Issuer
HARARI ELIYAHOU ET AL (1009165) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/26/2026 3:44 PM
CapsoVision (1378325) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2026 3:08 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2026 5:29 PM
CapsoVision (1378325) Issuer
Tsai Chen Lung (1307275) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:12 PM
CapsoVision (1378325) Issuer
GOUW JULIA S (1235498) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:15 PM
CapsoVision (1378325) Issuer
Harari Michele (2074161) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:18 PM
CapsoVision (1378325) Issuer
Imperial Joanne Carol (2075511) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:21 PM
CapsoVision (1378325) Issuer
King Wen-Herng Henry (2074258) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2026 5:23 PM
CapsoVision (1378325) Issuer
Kuo Hui Ying (2074262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2026 7:04 AM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2026 3:32 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2026 3:37 PM
CapsoVision (1378325) Issuer
Tsai Chen Lung (1307275) Reporting
Form 4/A
12/31/2025 4:09 PM
CapsoVision (1378325) Issuer
Tsai Chen Lung (1307275) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 4:09 PM
CapsoVision (1378325) Issuer
Kuo Hui Ying (2074262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 4:10 PM
CapsoVision (1378325) Issuer
King Wen-Herng Henry (2074258) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 4:10 PM
CapsoVision (1378325) Issuer
Imperial Joanne Carol (2075511) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 4:10 PM
CapsoVision (1378325) Issuer
GOUW JULIA S (1235498) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 4:11 PM
CapsoVision (1378325) Issuer
Harari Michele (2074161) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2025 3:10 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (Ad)

Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel

See Jeff Brown and Marc Chaikin's full analysis and next steps here
12/22/2025 3:19 PM
CapsoVision (1378325) Subject
Shen Ching Hang (2102304) Filed by
Form SCHEDULE 13G
11/13/2025 3:36 PM
CapsoVision (1378325) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2025 7:26 PM
CapsoVision (1378325) Subject
KIOXIA Corp (2095225) Filed by
Form SCHEDULE 13G
11/03/2025 8:08 PM
CapsoVision (1378325) Issuer
Garcia David Michael (2093112) Reporting
Form 3
Initial statement of beneficial ownership of securities  
11/03/2025 8:11 PM
CapsoVision (1378325) Issuer
Garcia David Michael (2093112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2025 7:01 AM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2025 3:10 PM
CapsoVision (1378325) Subject
CID Greater China Venture Capital Fund III, L.P. (2092240) Filed by
Form SCHEDULE 13G
10/14/2025 3:53 PM
CapsoVision (1378325) Subject
HARARI ELIYAHOU ET AL (1009165) Filed by
Form SCHEDULE 13G
09/17/2025 4:00 PM
CapsoVision (1378325) Issuer
Harari Michele (2074161) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 4:01 PM
CapsoVision (1378325) Issuer
GOUW JULIA S (1235498) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 4:01 PM
CapsoVision (1378325) Issuer
Imperial Joanne Carol (2075511) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 4:02 PM
CapsoVision (1378325) Issuer
King Wen-Herng Henry (2074258) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 4:02 PM
CapsoVision (1378325) Issuer
Kuo Hui Ying (2074262) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 4:02 PM
CapsoVision (1378325) Issuer
Tsai Chen Lung (1307275) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025 4:20 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025 7:44 PM
CapsoVision (1378325) Issuer
Petersen Rebecca Ann (2075458) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025 4:05 PM
CapsoVision (1378325) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2025 3:49 PM
CapsoVision (1378325) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

CapsoVision SEC Filings - Frequently Asked Questions

CapsoVision (CV) has submitted 83+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

CapsoVision's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 4 submitted on July 10, 2026. This was an insider ownership change filed by 4 - CapsoVision, Inc (0001378325) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:CV) was last updated on 7/16/2026 by MarketBeat.com Staff.
From Our Partners